Atlas Trials

The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters

Clinical trial NCT04824222 · UNKNOWN

Trial details

NCT number
NCT04824222
Sponsor
Medical University of Warsaw
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19
Start date
2021-04-01
Primary completion
2022-07-01
Enrollment
366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.